Skip to content

Clinical trials

Completed Triple Negative Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Completed Country / region: United Kingdom Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20123
20135
20142
20151
20163
20177
20181
20193
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
AbbVie1
AstraZeneca1
Bayer1
BeiGene1
Boston Pharmaceuticals1
Celgene1
Celldex Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms29
Breast Neoplasms8
Carcinoma, Non-Small-Cell Lung8
Colorectal Neoplasms5
Neoplasms5
Melanoma4
Neoplasm Metastasis4
Ovarian Neoplasms4
Pancreatic Neoplasms4
Stomach Neoplasms4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.